仁恒医药 (870511.OC)

+ 收藏

现金流量表(仁恒医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 23,997,410.9854,129,084.6121,309,130.6234,165,710.9115,746,431.13
 收到其他与经营活动有关的现金(元) 3,730,005.392,226,118.43792,134.52638,339.18343,086.38
 经营活动现金流入小计(元) 27,727,416.3756,355,203.0422,101,265.1434,804,050.0916,089,517.51
 购买商品、接受劳务支付的现金(元) 21,394,402.7528,192,596.1915,863,580.5113,694,057.2012,252,265.12
 支付给职工以及为职工支付的现金(元) 14,552,758.7322,012,287.2312,006,784.1717,057,856.707,832,240.89
 支付的各项税费(元) 4,333.55154,074.96884,643.3236,009.50283,133.81
 支付其他与经营活动有关的现金(元) 7,916,192.239,862,784.561,434,827.168,368,360.051,347,354.13
 经营活动现金流出小计(元) 43,867,687.2660,221,742.9430,189,835.1639,156,283.4521,714,993.95
 经营活动产生的现金流量净额(元) -16,140,270.89-3,866,539.90-8,088,570.02-4,352,233.36-5,625,476.44
二、投资活动产生的现金流量
 收回投资收到的现金(元) -7,700,000.00-10,300,000.001,800,000.00
 取得投资收益收到的现金(元) -58,805.72-84,948.0114,630.73
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 110,000.00----
 投资活动现金流入小计(元) 110,000.007,758,805.72-10,384,948.011,814,630.73
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,334,518.253,814,539.081,184,522.004,759,035.862,276,047.00
 投资支付的现金(元) -5,200,000.00-12,800,000.001,800,000.00
 支付其他与投资活动有关的现金(元) ---800,000.00-
 投资活动现金流出小计(元) 1,334,518.259,014,539.081,184,522.0018,359,035.864,076,047.00
 投资活动产生的现金流量净额(元) -1,224,518.25-1,255,733.36-1,184,522.00-7,974,087.85-2,261,416.27
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 17,400,000.0024,800,000.0013,800,000.0011,800,000.002,600,000.00
 收到其他与筹资活动有关的现金(元) --29,760.05--
 筹资活动现金流入小计(元) 17,400,000.0024,800,000.0013,829,760.0511,800,000.002,600,000.00
 偿还债务支付的现金(元) 4,400,000.0018,999,000.005,599,000.007,101,000.001,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 477,033.61625,671.92367,158.97558,023.01157,854.20
 支付其他与筹资活动有关的现金(元) 740,323.98979,394.85-327,547.50-
 筹资活动现金流出小计(元) 5,617,357.5920,604,066.775,966,158.977,986,570.511,157,854.20
 筹资活动产生的现金流量净额(元) 11,782,642.414,195,933.237,863,601.083,813,429.491,442,145.80
四、汇率变动对现金及现金等价物的影响(元) ---0.46-
五、现金及现金等价物净增加额(元) -5,582,146.73-926,340.03-1,409,490.94-8,512,891.26-6,444,746.91
 加:期初现金及现金等价物余额(元) 8,517,869.169,444,209.199,444,209.1917,957,100.4517,957,100.45
 期末现金及现金等价物余额(元) 2,935,722.438,517,869.168,034,718.259,444,209.1911,512,353.54
补充资料:
 净利润(元) 3,250,473.243,368,078.33-4,528,730.37-3,445,286.02482,775.18
 固定资产和投资性房地产折旧(元) 1,284,972.762,157,200.591,078,708.781,990,868.32729,667.30
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,284,972.762,157,200.591,078,708.781,990,868.32729,667.30
 无形资产摊销(元) 76,287.6779,403.7121,526.9518,053.889,026.94
 长期待摊费用摊销(元) 118,969.85245,023.2890,157.26233,356.84158,593.53
 处置固定资产、无形资产和其他长期资产的损失(元) 82,478.07---65,979.18-
 固定资产报废损失(元) ---31,466.12-
 公允价值变动损失(元) ----12,330.50-
 财务费用(元) 477,033.61702,109.17342,625.63592,613.01202,854.20
 投资损失(元) 10,187.60-39,530.81--84,914.94-
 递延所得税(元) -239,137.16-43,398.85--982,585.19-
  其中:递延所得税资产减少(元) -143,674.11-282,056.47--982,585.19-
 递延所得税负债增加(元) -95,463.05238,657.62---
 存货的减少(元) -16,903,541.75-9,662,243.35-5,550,304.93-1,438,256.83-24,786.30
 经营性应收项目的减少(元) -10,087,022.60-8,891,887.95-4,755,559.48-2,702,851.88-3,594,256.98
 经营性应付项目的增加(元) 4,642,104.976,310,575.445,213,006.141,000,063.01-3,589,350.31
 现金的期末余额(元) 2,935,722.438,517,869.168,034,718.259,444,209.1911,512,353.54
 减:现金的期初余额(元) 8,517,869.169,444,209.199,444,209.1917,957,100.4517,957,100.45
 现金及现金等价物的净增加额(元) -5,582,146.73-926,340.03-1,409,490.94-8,512,891.26-6,444,746.91
公告日期 2024-08-282024-04-292023-08-282023-04-252022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院